Related Experiment Videos
Hormonal modulation of B cell development and repertoire selection
Christine M Grimaldi1, Latia Hill, Xiaonan Xu
1Department of Medicine, Columbia University, 630 West 168th Street, PH 8E New York, NY 10032, USA.
Molecular Immunology
|April 15, 2005
Summary
Systemic lupus erythematosus (SLE) involves autoantibodies. Recent studies show estrogen and prolactin significantly impact SLE by affecting B cell tolerance and disease severity, explaining the gender bias.
Area of Science:
- Immunology
- Endocrinology
- Genetics
Background:
- Systemic lupus erythematosus (SLE) is an autoimmune disease marked by autoantibodies against nuclear antigens.
- Its exact cause is unknown, but genetics and environment are key factors.
- SLE predominantly affects females (9:1 ratio), suggesting a role for sex hormones.
Purpose of the Study:
- To review recent evidence on the role of estrogen and prolactin in SLE pathogenesis.
- To explore how these hormones influence B cell function in SLE.
- To understand the hormonal basis for the female predominance in SLE.
Main Methods:
- Review of recent human and mouse studies.
- Analysis of data on sex hormone levels and SLE.
- Examination of the effects of estrogen and prolactin on B cell maturation, selection, and activation.
Main Results:
- Compelling evidence links altered estrogen and prolactin levels to SLE.
- These hormones can disrupt B cell tolerance, worsening the disease.
- Data suggest a direct impact on B cell development and function.
Conclusions:
- Estrogen and prolactin are significant contributors to SLE pathogenesis.
- Hormonal imbalances exacerbate SLE by affecting B cell autoimmunity.
- Understanding these hormonal roles is crucial for SLE treatment and management.